DE602005016105D1 - Pharmazeutische zusammensetzungen mit zd6474 - Google Patents

Pharmazeutische zusammensetzungen mit zd6474

Info

Publication number
DE602005016105D1
DE602005016105D1 DE602005016105T DE602005016105T DE602005016105D1 DE 602005016105 D1 DE602005016105 D1 DE 602005016105D1 DE 602005016105 T DE602005016105 T DE 602005016105T DE 602005016105 T DE602005016105 T DE 602005016105T DE 602005016105 D1 DE602005016105 D1 DE 602005016105D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016105T
Other languages
English (en)
Inventor
Paul William Stott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE602005016105D1 publication Critical patent/DE602005016105D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005016105T 2004-05-21 2005-05-18 Pharmazeutische zusammensetzungen mit zd6474 Active DE602005016105D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0411378.3A GB0411378D0 (en) 2004-05-21 2004-05-21 Pharmaceutical compositions
PCT/GB2005/001931 WO2005112934A1 (en) 2004-05-21 2005-05-18 Pharmaceutical compositions comprising zd6474

Publications (1)

Publication Number Publication Date
DE602005016105D1 true DE602005016105D1 (de) 2009-10-01

Family

ID=32607743

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016105T Active DE602005016105D1 (de) 2004-05-21 2005-05-18 Pharmazeutische zusammensetzungen mit zd6474

Country Status (34)

Country Link
US (1) US8067427B2 (de)
EP (1) EP1753431B1 (de)
JP (1) JP4740947B2 (de)
KR (1) KR101192935B1 (de)
CN (1) CN101031303B (de)
AR (2) AR049059A1 (de)
AT (1) ATE439841T1 (de)
AU (1) AU2005244650B2 (de)
BR (1) BRPI0511253B8 (de)
CA (1) CA2565513C (de)
CY (1) CY1109500T1 (de)
DE (1) DE602005016105D1 (de)
DK (1) DK1753431T3 (de)
ES (1) ES2330025T3 (de)
GB (1) GB0411378D0 (de)
HK (1) HK1099220A1 (de)
HR (1) HRP20090547T1 (de)
IL (1) IL178928A (de)
ME (2) ME02778B (de)
MX (1) MXPA06013501A (de)
MY (1) MY138868A (de)
NO (1) NO338324B1 (de)
NZ (1) NZ550931A (de)
PL (1) PL1753431T3 (de)
PT (1) PT1753431E (de)
RS (1) RS51112B (de)
RU (1) RU2383343C2 (de)
SA (1) SA05260133B1 (de)
SI (1) SI1753431T1 (de)
TW (1) TWI355269B (de)
UA (1) UA81732C2 (de)
UY (1) UY28901A1 (de)
WO (1) WO2005112934A1 (de)
ZA (1) ZA200609110B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2278511B1 (es) * 2005-07-28 2008-06-16 Laboratorios Almirall S.A. Comprimidos con perfil de disolucion mejorado.
PT3039424T (pt) 2013-08-28 2020-09-03 Crown Bioscience Inc Taicang Assinaturas de expressão genética que permitem prever a resposta de um sujeito a um inibidor multiquinase e métodos de utilização do mesmo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718972D0 (en) * 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
PT1244647E (pt) 1999-11-05 2006-10-31 Astrazeneca Ab Derivados de quinazolina como inibidores de vegf
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
KR100419555B1 (ko) * 2000-05-29 2004-02-19 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
WO2003074045A1 (fr) * 2002-03-05 2003-09-12 Eisai Co., Ltd. Agent antitumoral comprenant une combinaison d'un compose heterocyclique contenant un sulfamide et d'un inhibiteur d'angiogenese

Also Published As

Publication number Publication date
HK1099220A1 (en) 2007-08-10
TWI355269B (en) 2012-01-01
US20070244323A1 (en) 2007-10-18
NZ550931A (en) 2009-05-31
HRP20090547T1 (en) 2009-11-30
KR20070034499A (ko) 2007-03-28
CY1109500T1 (el) 2014-08-13
NO20065735L (no) 2006-12-19
AU2005244650B2 (en) 2008-04-10
US8067427B2 (en) 2011-11-29
AR110045A2 (es) 2019-02-20
PL1753431T3 (pl) 2009-12-31
MY138868A (en) 2009-08-28
CA2565513C (en) 2010-10-19
AR049059A1 (es) 2006-06-21
UA81732C2 (ru) 2008-01-25
CA2565513A1 (en) 2005-12-01
EP1753431A1 (de) 2007-02-21
BRPI0511253B1 (pt) 2020-03-31
TW200612953A (en) 2006-05-01
ES2330025T3 (es) 2009-12-03
EP1753431B1 (de) 2009-08-19
MXPA06013501A (es) 2007-06-12
ME02778B (me) 2010-10-31
CN101031303B (zh) 2011-08-31
IL178928A0 (en) 2007-03-08
BRPI0511253A (pt) 2007-11-27
SA05260133B1 (ar) 2008-12-23
RU2383343C2 (ru) 2010-03-10
PT1753431E (pt) 2009-10-14
RU2006145357A (ru) 2008-06-27
SI1753431T1 (sl) 2009-12-31
ZA200609110B (en) 2008-06-25
GB0411378D0 (en) 2004-06-23
RS51112B (sr) 2010-10-31
JP2007538060A (ja) 2007-12-27
WO2005112934A1 (en) 2005-12-01
ATE439841T1 (de) 2009-09-15
KR101192935B1 (ko) 2012-10-18
BRPI0511253B8 (pt) 2021-05-25
JP4740947B2 (ja) 2011-08-03
NO338324B1 (no) 2016-08-08
ME01505B (me) 2014-04-20
DK1753431T3 (da) 2009-11-16
CN101031303A (zh) 2007-09-05
AU2005244650A1 (en) 2005-12-01
IL178928A (en) 2012-04-30
UY28901A1 (es) 2005-12-30

Similar Documents

Publication Publication Date Title
BRPI0511900A (pt) composições farmacêuticas
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
DE602005012107D1 (de) Pharmazeutische formulierungen mit einem antibioti
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
DE602007010797D1 (de) Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
DE602005026188D1 (de) Medikamentenspender
DK2783682T3 (da) Farmaceutisk sammensætning omfattende pimobendan
ATE453384T1 (de) Neue dosierformulierung
ATE493119T1 (de) Pharmazeutische zusammensetzung
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
DK1587478T3 (da) Farmaceutisk sammensætning
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
DK2918286T3 (da) En farmaceutisk formulering
DE60305728D1 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
DE602004024220D1 (de) Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung
IS8559A (is) Lyfjasamsetning gegn sveppagerlum
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin
DE602006017975D1 (de) Feste pharmazeutische zusammensetzung mit telithromycin
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
DE602005016105D1 (de) Pharmazeutische zusammensetzungen mit zd6474
DE602005005033D1 (de) Sprühgetrocknete pharmazeutische zusammensetzungen
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
NO20051756D0 (no) Stol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition